These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 27519586

  • 1. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ, Adhikary G, Ali MW, Ahmed S, Shamsuzzaman M, Odell C, Hashiguchi L, Lim SS, Alam N.
    BMC Infect Dis; 2016 Aug 12; 16():411. PubMed ID: 27519586
    [Abstract] [Full Text] [Related]

  • 2. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S, Tabu C, N'ganga J, Awes AA, Sergon K, Cosmas L, Styczynski A, Thuo S, Lebo E, Kaiser R, Perry R, Ademba P, Kretsinger K, Onuekwusi I, Gary H, Scobie HM.
    PLoS One; 2018 Aug 12; 13(7):e0199786. PubMed ID: 29965975
    [Abstract] [Full Text] [Related]

  • 3. Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
    Thangaraj JWV, Prosperi C, Kumar MS, Hasan AZ, Kumar VS, Winter AK, Bansal AK, Chauhan SL, Grover GS, Jain AK, Kulkarni RN, Sharma SK, Soman B, Chaaithanya IK, Kharwal S, Mishra SK, Salvi NR, Sarmah NP, Sharma S, Varghese A, Sabarinathan R, Duraiswamy A, Rani DS, Kanagasabai K, Lachyan A, Gawali P, Kapoor M, Chonker SK, Sangal L, Mehendale SM, Sapkal GN, Gupta N, Hayford K, Moss WJ, Murherkar MV.
    PLoS One; 2024 Aug 12; 19(3):e0297385. PubMed ID: 38551928
    [Abstract] [Full Text] [Related]

  • 4. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A, Vincent A, Selvaraj K, Manikandan M.
    Rural Remote Health; 2019 Sep 12; 19(3):5261. PubMed ID: 31529972
    [Abstract] [Full Text] [Related]

  • 5. Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh.
    Khan AI, Islam MT, Siddique SA, Ahmed S, Sheikh N, Siddik AU, Islam MS, Qadri F.
    Hum Vaccin Immunother; 2019 Sep 12; 15(12):2882-2886. PubMed ID: 31441679
    [Abstract] [Full Text] [Related]

  • 6. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
    Danovaro-Holliday MC, Rhoda DA, Lacoul M, Prier ML, Gautam JS, Pokhrel TN, Dixit SM, Rajbhandari RM, Bose AS.
    BMC Public Health; 2022 Feb 03; 22(1):221. PubMed ID: 35114969
    [Abstract] [Full Text] [Related]

  • 7. Social capital, trust in health information, and acceptance of Measles-Rubella vaccination campaign in Tamil Nadu: A case-control study.
    Palanisamy B, Gopichandran V, Kosalram K.
    J Postgrad Med; 2018 Feb 03; 64(4):212-219. PubMed ID: 29943738
    [Abstract] [Full Text] [Related]

  • 8. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec 03; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 9. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [Abstract] [Full Text] [Related]

  • 10. Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland.
    Paunio M, Virtanen M, Peltola H, Cantell K, Paunio P, Valle M, Karanko V, Heinonen OP.
    Am J Epidemiol; 1991 Jun 01; 133(11):1152-60. PubMed ID: 2035518
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of vaccination coverage of measles-rubella campaign in Imphal East District, Manipur: A cross-sectional study.
    Rajkumari B, Keisam A, Haobam DS, Thounaojam T.
    Indian J Public Health; 2020 Jun 01; 64(2):173-177. PubMed ID: 32584301
    [Abstract] [Full Text] [Related]

  • 12. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, Lacapere F, Mung K, Luman ET.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S616-21. PubMed ID: 21954256
    [Abstract] [Full Text] [Related]

  • 13. Implementation of the World's largest measles-rubella mass vaccination campaign in Bangladesh: a process evaluation.
    Sarma H, Budden A, Luies SK, Lim SS, Shamsuzzaman M, Sultana T, Rajaratnam JK, Craw L, Banwell C, Ali MW, Uddin MJ.
    BMC Public Health; 2019 Jul 10; 19(1):925. PubMed ID: 31291922
    [Abstract] [Full Text] [Related]

  • 14. Factors affecting non-coverage of measles-rubella vaccination among children aged 9-59 months in Tanzania.
    Mkopi A, Mtenga S, Festo C, Mhalu G, Shabani J, Tillya R, Masemo A, Kheir K, Nassor M, Mwengee W, Lyimo D, Masanja H.
    Vaccine; 2021 Oct 01; 39(41):6041-6049. PubMed ID: 34531077
    [Abstract] [Full Text] [Related]

  • 15. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ, Orenstein WA.
    Vaccine; 2018 Sep 05; 36(37):5645-5650. PubMed ID: 30041881
    [Abstract] [Full Text] [Related]

  • 16. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA, François J, Wannemuehler K, Magloire R, Danovaro-Holliday MC, Flannery B, Cavallaro KF, Fitter DL, Purcell N, Dismer A, Tappero JW, Vertefeuille JF, Hyde TB.
    Trop Med Int Health; 2014 Sep 05; 19(9):1105-15. PubMed ID: 25041586
    [Abstract] [Full Text] [Related]

  • 17. Micro-planning in a wide age range measles rubella (MR) campaign using mobile phone app, a case of Kenya, 2016.
    Ismail A, Tabu C, Onuekwusi I, Otieno SK, Ademba P, Kamau P, Koki B, Ngatia A, Wainaina A, Davis R.
    Pan Afr Med J; 2017 Sep 05; 27(Suppl 3):16. PubMed ID: 29296151
    [Abstract] [Full Text] [Related]

  • 18. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.
    Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654
    [Abstract] [Full Text] [Related]

  • 19. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM, Badizadegan ND.
    Risk Anal; 2017 Jun 31; 37(6):1109-1131. PubMed ID: 28561947
    [Abstract] [Full Text] [Related]

  • 20. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K, Mutembo S, Carcelen A, Matakala HK, Munachoonga P, Winter A, Wanyiri JW, Searle K, Mwansa FD, Mwiche A, Phiri C, Book C, Thuma PE, Moss WJ.
    Vaccine; 2019 Apr 17; 37(17):2387-2393. PubMed ID: 30905529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.